Evidence method
Level · gp.fundamentals.capex_revenue_ratio
75.65% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
IMDX · Sep 30, 2024
Insight Molecular Diagnostics Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000950170-24-125365General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-4826.96% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
-73.19% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
201.74% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
43.48% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-11752.17% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2449.57% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
391.30% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History15 statesHistory building
Dec 31, 20220/6 normalizedLevel 3Mar 31, 20230/5 normalizedLevel 3Jun 30, 20230/5 normalizedLevel 3Sep 30, 20230/5 normalizedLevel 3Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/7 normalizedLevel 3Jun 30, 20240/7 normalizedLevel 3Sep 30, 20240/8 normalizedLevel 3Dec 31, 20245/8 normalizedLevel 3Mar 31, 20255/8 normalizedLevel 3Jun 30, 20255/8 normalizedLevel 3Sep 30, 20256/8 normalizedLevel 3Dec 31, 20257/8 normalizedLevel 3Mar 31, 20267/8 normalizedLevel 3Jun 30, 20267/8 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 183.65%
- Current
- 75.65%
- Delta
- -108.00%
- Previous
- -5748.08%
- Current
- -4826.96%
- Delta
- 921.12%
- Previous
- -77.54%
- Current
- -73.19%
- Delta
- 4.34%
- Previous
- 48.08%
- Current
- 43.48%
- Delta
- -4.60%
- Previous
- -4453.85%
- Current
- -11752.17%
- Delta
- -7298.33%
- Previous
- 2358.65%
- Current
- 2449.57%
- Delta
- 90.91%
- Previous
- 371.15%
- Current
- 391.30%
- Delta
- 20.15%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · IMDX Fundamental State →Transitioned To · IMDX Fundamental State →Transitioned To · IMDX CAPEX_INTENSITY_DECREASED →Transitioned To · IMDX CASH_GENERATION_INCREASED →Transitioned To · IMDX GROWTH_INCREASED →Transitioned To · IMDX MARGIN_DECREASED →Transitioned To · IMDX PROFITABILITY_DECREASED →Transitioned To · IMDX R_AND_D_INTENSITY_INCREASED →Transitioned To · IMDX SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.